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In the general population, adrenal masses are demon-
strated in 2-9% of CT scans. Eighty per cent of these are
benign cortical adenomas. However, in patients with
cancer, over 50% of detected adrenal masses prove to be
metastases. Despite this the techniques for the evaluation
of adrenal masses in patients with cancer should be similar
to patients without cancer and incidentally discovered
adrenal masses. Extensive published material is now
available on the diagnostic performance of CT, MRI and
PET in the characterization of adrenal masses. It must be
borne in mind, however, that these techniques are usually
evaluated for their ability to positively identify adenomas.
Other adrenal pathology also occurs incidentally and it is
essential that the radiologist should be familiar with the
range of appearances of this pathology. Examples of this
include phaeochromocytomas, cysts, myelolipomas,
haemorrhage and granulomatous infections. Furthermore,
although cross-sectional imaging techniques, particularly
when modified specifically to evaluate indeterminate
adrenal masses, can prove to have an excellent diagnostic
performance (with remarkably high specificity), all have
limitations. It is a consideration of the relative comparative
strengths and weaknesses of each of these imaging
modalities that informs the choice of technique and inter-
pretation of the findings. This short presentation outlines
the key points relating to the most widely used techniques
for evaluating the adrenal mass in patients with cancer
and the evidence for their role in patient management.
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